cardiac failure Articles
-
Simulating Cardiac Fibrosis
InvivoSciences, Inc. is collaborating with Drs. Elson and Qian to establish a novel mathematical model to understand the development of cardiac fibrosis during heart failure. The model will be used to identify and validate new therapeutic targets to prevent, slow, or reverse cardiac fibrosis. ...
-
Cardiovascular Consequences of Acute Kidney Injury
Annotations Acute kidney injury (AKI) is recognized as a potential risk factor for future cardiovascular events, especially heart failure. Up to 60% of patients with severe AKI who are admitted to an intensive care unit (ICU) die; the long-term risk of death associated with AKI is also increased. Preclinical models and biomarkers have identified several likely pathways, apparently involving ...
-
What’s the difference between a heart attack, cardiac arrest and heart failure?
While heart attack, cardiac arrest and heart failure can sometimes be related, they’re actually three very different types of cardiac emergencies. Cardiac arrest, heart attack and heart failure — three terms that are familiar to most people, but often get confused with one another. While there can be some overlap between them in terms of cause and effect, they are actually three ...
-
What is heart failure with preserved ejection fraction (HFpEF)?
Overview What is HFpEF? Heart failure with preserved ejection fraction (HFpEF) is a clinical syndrome in which patients have signs and symptoms of HF as the result of high left ventricular (LV) filling pressure, despite normal or near-normal LV ejection fraction (EF). Most patients with HFpEF also display normal LV volumes and an abnormal diastolic filling pattern (i.e, diastolic ...
-
Baroreflex Activation Therapy: A Novel Approach for HFrEF Patients
During the webinar, you’ll learn about: Treatment options and unmet needs of HFrEF patients The physiologic rationale of baroreflex activation Barostim therapy overview and clinical evidence overview Appropriate patient selection and real-world experience Important Safety Information CAUTION: Federal law restricts this device to sale by or on the ...
By CVRx
-
Conceptual Considerations for Device-Based Therapy in Acute Decompensated Heart Failure
Abstract Acute decompensated heart failure remains the most common cause of hospitalization in older adults, and studies of pharmacological therapies have yielded limited progress in improving outcomes for these patients. This has prompted the development of novel device–based interventions, classified mechanistically based on the way in which they intend to improve central hemodynamics, ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you